APA (7th ed.) Citation

Ohata, S., Takenaka, K., Sugiyama, D., & Sugimoto, T. Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma. Wiley.

Chicago Style (17th ed.) Citation

Ohata, Shinya, Kei Takenaka, Daisuke Sugiyama, and Takeshi Sugimoto. Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma. Wiley.

MLA (9th ed.) Citation

Ohata, Shinya, et al. Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma. Wiley.